fr 41565 has been researched along with Malignant Melanoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Inamura, N; Kunishige, E; Nakanishi, M; Ogura, T; Okubo, A; Sone, S | 1 |
| Inamura, N; Nii, A; Ogura, T; Okubo, A; Sone, S | 1 |
| Aoki, H; Gotoh, T; Imanaka, H; Inamura, N; Kawamura, I; Kino, T; Nakahara, K; Sone, S | 1 |
3 other study(ies) available for fr 41565 and Malignant Melanoma
| Article | Year |
|---|---|
Tumor cytotoxicity of human monocyte membrane-bound interleukin-1 alpha induced by synergistic actions of interferon-gamma and synthetic acyltripeptide, FK-565.
Topics: Antineoplastic Agents; Cell Line; Drug Synergism; Fixatives; Formaldehyde; Humans; Immune Sera; Interferon-gamma; Interleukin-1; Macrophage Activation; Melanoma; Membrane Proteins; Monocytes; Oligopeptides; Polymers; Recombinant Proteins; Tumor Necrosis Factor-alpha | 1989 |
Synergism of synthetic acyltripeptide and its analogs with recombinant interferon gamma for activation of antitumor properties of human blood monocytes.
Topics: Adjuvants, Immunologic; Cell Line; Cytotoxicity, Immunologic; Drug Synergism; Humans; Interferon Type I; Interferon-gamma; Macrophage Activation; Melanoma; Monocytes; Oligopeptides; Recombinant Proteins | 1988 |
Activation of tumoricidal properties in macrophages and inhibition of experimentally-induced murine metastases by a new synthetic acyltripeptide, FK-565.
Topics: Adjuvants, Immunologic; Amino Acids, Diamino; Animals; Cell Line; Cytotoxicity, Immunologic; Diaminopimelic Acid; Female; Lung Neoplasms; Macrophages; Melanoma; Mice; Mice, Inbred C57BL; Oligopeptides | 1985 |